The role of thrombin in the pathogenesis of atherosclerosis and its complications
- 31 March 2022
- journal article
- review article
- Published by APO Society of Specialists in Heart Failure in Kardiologiia
- Vol. 62 (3) , 73-81
Abstract
Thrombin is a key regulator of the homeostasis system. Also, it actively participates in progression of various systemic diseases, including atherosclerosis. There is a large amount of experimental and clinical data on the involvement of thrombin in the pathogenesis of ischemic heart disease (IHD). Thus, studying thrombin activity regulation is promising. Also, the question whether it is possible to use biomarkers of thrombin activity as predictors of cardiovascular complications in IHD patients is relevant. The present review focuses on major mechanisms of thrombin functioning, its role in development and progression of atherosclerosis, and available tests for evaluation of thrombin functional activity. Major clinical studies are discussed that evaluated the efficacy of thrombin inhibitors and protease-activated receptor antagonists.Keywords
This publication has 105 references indexed in Scilit:
- Thrombin Generation in the Glasgow Myocardial Infarction StudyPLOS ONE, 2013
- Platelet Reactivity and Intramyocardial Hemorrhage in Patients With ST-Segment Elevation Myocardial InfarctionClinical and Applied Thrombosis/Hemostasis, 2013
- Accelerated In Vivo Thrombin Formation Independently Predicts the Presence and Severity of CT Angiographic Coronary AtherosclerosisJACC: Cardiovascular Imaging, 2012
- Direct thrombin inhibitors for management of heparin-induced thrombocytopenia in patients receiving renal replacement therapy: Comparison of clinical outcomesAmerican Journal of Health-System Pharmacy, 2012
- Vorapaxar in the Secondary Prevention of Atherothrombotic EventsNew England Journal of Medicine, 2012
- Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary SyndromesNew England Journal of Medicine, 2012
- Direct thrombin inhibitorsBritish Journal of Clinical Pharmacology, 2011
- Randomized Trial of Atopaxar in the Treatment of Patients With Coronary Artery DiseaseCirculation, 2011
- Is thrombin a key player in the 'coagulation-atherogenesis' maze?Cardiovascular Research, 2009
- Thrombin Facilitation of Voltage-Gated Sodium Channel Activation in Human CardiomyocytesCirculation, 2002